These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 225004)

  • 1. Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
    Avellanosa AM; West CR; Tsukada Y; Higby DJ; Bakshi S; Reese PA; Jennings E
    Cancer; 1979 Sep; 44(3):839-46. PubMed ID: 225004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
    West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
    Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
    Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
    Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors.
    Gutin PH; Wilson CB; Kumar AR; Boldrey EB; Levin V; Powell M; Enot KJ
    Cancer; 1975 May; 35(5):1398-404. PubMed ID: 1122488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glioma.
    Costanza M; Buechler M; Munzenreider J; Emami B; Mukherji B; Shucart W; Scott M; Nathanson L; Rudders R; Stein B; Post K; Piro A
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1589-92. PubMed ID: 231595
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
    Crafts DC; Levin VA; Edwards MS; Pischer TL; Wilson CB
    J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
    Carmo-Pereira J; Costa FO; Pimentel P; Henriques E
    Cancer Treat Rep; 1980 Jan; 64(1):143-5. PubMed ID: 7379048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D; Sipos L; Vitanovics D
    Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
    Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosourea chemotherapy for primary malignant gliomas.
    Levin VA; Wilson CB
    Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.
    Shapiro WR; Young DF
    Trans Am Neurol Assoc; 1976; 101():217-20. PubMed ID: 1028239
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
    Einhorn LH; Furnas B
    Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCV chemotherapy for recurrent glioblastoma.
    Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M
    Neurology; 2006 Feb; 66(4):587-9. PubMed ID: 16505319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
    Brufman G; Halpern J; Sulkes A; Catane R; Biran S
    Oncology; 1984; 41(4):239-41. PubMed ID: 6462602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
    Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
    Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
    J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.